Mrs Amber Van Broekhoven
Radboud University Nijmegen, Nijmegen (Netherlands (The))
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
End-of-trial inflammatory biomarkers, lipid levels, creatine kinase and markers of renal and liver function in the LoDoCo2 trial.
Event: ESC Congress 2022
Topic: Prevention
Session: Coronary artery disease - Prevention
ESC 365 is supported by
